Login / Signup

Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.

Karyn GerstleAmir SiddiquiJefree J SchulteSusan L Cohn
Published in: Pediatric blood & cancer (2020)
Opsoclonus myoclonus syndrome (OMS) is a rare neurological syndrome caused by a paraneoplastic autoimmune process that affects children with neuroblastic tumors. Treatment includes corticosteroids, intravenous gamma globulin (IVIG), rituximab, and other immunosuppressive therapies. Here, we describe a patient diagnosed with OMS associated with a localized inflammatory myofibroblastic tumor. The patient has no evidence of tumor recurrence following surgical resection with 8-month follow-up. The neurologic symptoms resolved with corticosteroids and IVIG. This case demonstrates that in children, neoplasms other than neuroblastoma may be associated with this paraneoplastic syndrome, and highlights the importance of evaluating patients with OMS for underlying malignancies.
Keyphrases
  • case report
  • young adults
  • oxidative stress
  • multiple sclerosis
  • high dose
  • depressive symptoms
  • diffuse large b cell lymphoma
  • brain injury
  • sleep quality
  • replacement therapy